2009
The relationship between handedness and risk of multiple sclerosis
Gardener H, Munger K, Chitnis T, Spiegelman D, Ascherio A. The relationship between handedness and risk of multiple sclerosis. Multiple Sclerosis Journal 2009, 15: 587-592. PMID: 19389750, PMCID: PMC2771381, DOI: 10.1177/1352458509102622.Peer-Reviewed Original ResearchConceptsMultiple sclerosisHealth StudyHand preferenceOngoing prospective cohort studyUtero hormone exposureNurses' Health StudyProspective cohort studyMultiple sclerosis riskSex steroid hormonesLeft-handed womenLeft-handed individualsCohort studyAutoimmune disordersIncident casesUtero exposureUnknown etiologyPrenatal exposureSex hormonesImmune disordersStudy populationHormone exposureSclerosisFemale nursesSteroid hormonesRisk
2005
Temporal Relationship Between Elevation of Epstein-Barr Virus Antibody Titers and Initial Onset of Neurological Symptoms in Multiple Sclerosis
Levin LI, Munger KL, Rubertone MV, Peck CA, Lennette ET, Spiegelman D, Ascherio A. Temporal Relationship Between Elevation of Epstein-Barr Virus Antibody Titers and Initial Onset of Neurological Symptoms in Multiple Sclerosis. JAMA 2005, 293: 2496-2500. PMID: 15914750, DOI: 10.1001/jama.293.20.2496.Peer-Reviewed Original ResearchConceptsViral capsid antigenEpstein-Barr virusMultiple sclerosisAntibody titersEBNA complexRelative riskDevelopment of MSEBV viral capsid antigenEpstein-Barr virus (EBV) antibody titersRisk of MSOnset of MSOnset of symptomsVirus antibody titersSerum antibody titersCase-control studyDefense Serum RepositoryAge 25 yearsBlood sample collectionUS military personnelTemporal relationshipCase-control setsRace/ethnicityAge-dependent relationshipEBV infectionCytomegalovirus antibodies
2003
Multiple Sclerosis and Epstein-Barr Virus
Levin LI, Munger KL, Rubertone MV, Peck CA, Lennette ET, Spiegelman D, Ascherio A. Multiple Sclerosis and Epstein-Barr Virus. JAMA 2003, 289: 1533-1536. PMID: 12672770, DOI: 10.1001/jama.289.12.1533.Peer-Reviewed Original ResearchConceptsViral capsid antigenEpstein-Barr virusRisk of MSMultiple sclerosisRelative riskDevelopment of MSEBV viral capsid antigenOnset of MSCase-control studyDefense Serum RepositoryBlood sample collectionUS military personnelRace/ethnicityEBNA complexEBV antibodiesEBV infectionCytomegalovirus antibodiesSerum levelsCapsid antigenEarly antigenMS onsetAntibody titersIgG antibodiesPermanent disabilitySerum Repository
2001
Epstein-Barr Virus Antibodies and Risk of Multiple Sclerosis: A Prospective Study
Ascherio A, Munger KL, Lennette ET, Spiegelman D, Hernán MA, Olek MJ, Hankinson SE, Hunter DJ. Epstein-Barr Virus Antibodies and Risk of Multiple Sclerosis: A Prospective Study. JAMA 2001, 286: 3083-3088. PMID: 11754673, DOI: 10.1001/jama.286.24.3083.Peer-Reviewed Original ResearchConceptsEpstein-Barr virusViral capsid antigenCases of MSGeometric mean titersHealth Study IIMultiple sclerosisSerum antibody titersRelative riskAntibody titersDisease onsetEBNA-2Health StudyRole of EBVNurses' Health Study IIEBV viral capsid antigenEpstein-Barr virus antibodiesEtiology of MSOccurrence of MSHealthy age-matched controlsNurses' Health StudyCorresponding relative risksCase-control studyAge-matched controlsCMV antigensEBV antibodies
2000
Oral contraceptives and the incidence of multiple sclerosis
Hernán M, Hohol MJ, Olek MJ, Spiegelman D, Ascherio A. Oral contraceptives and the incidence of multiple sclerosis. Neurology 2000, 55: 848-853. PMID: 10994007, DOI: 10.1212/wnl.55.6.848.Peer-Reviewed Original ResearchConceptsRisk of MSHealth Study IIOral contraceptive useOral contraceptivesContraceptive useProtective effectHealth StudyNurses' Health Study IIAge-adjusted relative riskOral contraceptive historiesNurses' Health StudyProgression of MSDiagnosis of MSDuration of useCohort studyMS incidenceMS riskHormonal contraceptionMultiple sclerosisContraceptive historyRelative riskClinical dataProbable casesU.S. womenPast users